BIIB 8-K 2026-01-13

BIOGEN INC. (BIIB) 8-K dated 2026-01-13 — accession 0000875045-26-000003. This URL is the filing, not the BIIB hub.

BIOGEN INC. (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.

BIOGEN INC. filed a 8-K on 2026-01-13. Accession 0000875045-26-000003.

Cached items: 2.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.

Not investment advice. The BIIB SEC hub lists recent forms. The stock page is the research view.